|
| |
| | | 62812 | | 17.01.2014 | | Novartis Pharma Schweiz AG | | | | | | | | | | | | | 07.16.40. | | | | 07.16.40. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Votubia 2 mg | dispergierbare Tabletten | Dispersible Tabletten (Everolimus 2 mg) | L01XE10 | PI | | 02 | Votubia 3 mg | dispergierbare Tabletten | Dispersible Tabletten (Everolimus 3 mg) | L01XE10 | PI |
|
|
|
